A tighter archive for life-science signals.
Search once, then narrow by source or topic.
FDA refuses to review Moderna’s mRNA flu vaccine
FDA refuses to review Moderna’s mRNA flu vaccine
Gilead dips as ‘strong’ earnings outweighed by high expectations for new HIV drug
Gilead dips as ‘strong’ earnings outweighed by high expectations for new HIV drug
Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study
Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study
FDA rejects Regenxbio treatment in another blow to gene therapy
FDA rejects Regenxbio treatment in another blow to gene therapy
Lilly buys ‘in vivo’ CAR-T maker Orna, extending streak of genetic medicine deals
Lilly buys ‘in vivo’ CAR-T maker Orna, extending streak of genetic medicine deals
Lilly bets again on China drugs; Roche showcases MS data
Lilly bets again on China drugs; Roche showcases MS data
Takeda, Iambic partner in latest pharma AI push
Takeda, Iambic partner in latest pharma AI push
Hengrui, Kailera tout positive results for dual-acting obesity pill
Hengrui, Kailera tout positive results for dual-acting obesity pill
Small and mighty: single-domain antibodies pack a biological punch
Small and mighty: single-domain antibodies pack a biological punch
Navigating the complexities of Cell and Gene Therapy supply chains
Navigating the complexities of Cell and Gene Therapy supply chains
Hims cancels plans to sell compounded GLP-1 pill after FDA backlash
Hims cancels plans to sell compounded GLP-1 pill after FDA backlash
White House’s online service for drug sales debuts with limited impact on prices
White House’s online service for drug sales debuts with limited impact on prices
Agomab, SpyGlass bank a combined $350M in biotech IPOs
Agomab, SpyGlass bank a combined $350M in biotech IPOs
Earnings roundup: AbbVie angst, a bifurcated vaccine market and Bristol Myers’ waiting game
Earnings roundup: AbbVie angst, a bifurcated vaccine market and Bristol Myers’ waiting game
Novo, Lilly sputter as Hims launches knockoff GLP-1 pill
Novo, Lilly sputter as Hims launches knockoff GLP-1 pill
Bayer details anticipated stroke prevention data for new blood-thinner
Bayer details anticipated stroke prevention data for new blood-thinner
Generate, an AI-driven Flagship startup, pitches an IPO
Generate, an AI-driven Flagship startup, pitches an IPO
Express Scripts reaches ‘landmark’ settlement with FTC in insulin suit
Express Scripts reaches ‘landmark’ settlement with FTC in insulin suit
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page